test 6 part 2 Flashcards

1
Q

Diuretics

A

 Increase the volume of urine excreted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Proximal convoluted tubule reabsorption

A

 Almost 100%: glucose, amino acids, metabolites

 65%: H2O, Na, Cl, K, bicarbonate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Proximal convoluted tubule secretion

A

 H+
 Organic acids and bases
 Catecholamines
 Drugs/toxins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Descending loop of henle

A
  • H2O reabsorbed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Ascending loop of henle reabsorbed

A

 Impermeable to water!
 25%: Na, Cl, K
 Ca, bicarbonate, magnesium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ascending loop of henle secreted

A

 H+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Early Distal convoluted tubule

A

 Impermeable to water!

 5%: Na, Cl, K reabsorbed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Late distal tubule and cortical collecting tubule reabsorbed

A
 H2O in the presence of Antidiuretic hormone (ADH)
 Principal cells
        - Na+
 Intercalated cells
        - Bicarb, K+, and H+
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Late distal tubule and cortical collecting tubule excreted

A

 Principal cells
- K+
 Intercalated cells
- Bicarb, K+, and H+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Medullary collecting duct reabsorbed

A

 10%: Na, H2O (when ADH present)

 Urea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Medullary collecting duct secreted

A

 H+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Common uses of diuretics

A
Hypertension
Edema associated with
         Congestive heart failure
         Liver cirrhosis
         Corticosteroid therapy
         Renal dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Types of diuretics

A
Thiazide
Loop
Potassium-Sparing
Carbonic Anhydrase Inhibitors
Osmotic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Thiazide diuretics

A

Most widely used
Affect distal convoluted tubule
All have same Emax, different potencies
Effective orally
1-3 weeks for stable blood pressure reduction
- “low ceiling diuretics” = giving more than therapeutically required won’t do anything

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Thiazide diuretics affect which transporter

A
  • Na/Cl cotransporter on luminal membrane

- in distal convoluted tubule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Thiazide diuretics enter lumen where and how

A
  • Secreted into the lumen in the proximal tubule via the organic acid secretory system
17
Q

Thiazide diuretic actions

A

 Increased excretion of Na and Cl
 Very hyperosmolar urine
 Unique to thiazides
 Loss of K+ (Na/K countertransport mech on luminal side)
 Sodium concentration in filtrate is high when it reaches distal tubule
 More K+ is exchanged for Na+
 Loss of Mg2+ (supplementation of Mg2+ required with chronic use)
 Decreased excretion of calcium
 Increased reabsorption in distal convoluted tubule
 Reduced PVR
 Over time volume status returns but PVR remains low

18
Q

Thiazide diuretics therapeutic uses

A

 Hypertension
 Heart failure
 Hypercalciuria
 Diabetes insipidus

19
Q

Thiazide diuretics adverse effects

A
 Potassium depletion
 Hyponatremia
 Hyperuricemia
 Volume depletion
 Hypercalcemia
 Hyperglycemia
20
Q

Loop diuretics

A

 Major action on ascending Loop of Henle
 Act on luminal side
 Highest efficacy in removing Na+ and Clfrom
the body
 Produce copious amounts of urine
 Oral or IV
 Rapid onset, short duration (2-4 hours)
- greatest diuretic effect

21
Q

Loop diuretics act on what transporter

A
  • Na/2Cl/K cotransporter luminal membrane

- ascending loop of henle

22
Q

Loop diuretics and renal blood flow

A

 Quick response
 May increase renal blood flow due to prostaglandin synthesis
 NSAIDS inhibit renal prostaglandin synthesis and can reduce the diuretic action

23
Q

Loop diuretics therapeutic uses

A

 Peripheral and pulmonary edema (HF)
 Emergency situations (Acute pulmonary edema)
 Hypercalcemia
 Hyperkalemia
- Diuretic of choice even in patients with compromised renal function

24
Q

Loop diuretics perfusion uses

A

 Remove extra fluid on CPB
 Treat hyperkalemia
 Help maintain urine production and renal function

25
Q

Adult pump dose of loop diuretics

A

20-40 mg bolus

26
Q

Loop diuretics adverse effects

A
 Ototoxicity
 Hyperuricemia
 Acute hypovolemia
 Potassium depletion
 Hypomagnesemia
27
Q

Potassium-sparing diuretics: aldosterone antagonists

A

 Block aldosterone action
 Mediator proteins that normally stimulate the Na+/K+ pump are not produced
 Retention of K+
 Excretion of Na+

28
Q

Potassium-sparing diuretics: aldosterone antagonists therapeutic uses

A

 Diuresis
 Low efficacy in removing Na+ from body
 Useful for retention of K+
 Given in conjunction with thiazide or loop diuretics
 Secondary hyperaldosteronism
 Hepatic cirrhosis
 Nephrotic syndrome
 Heart failure
 Resistant hypertension
 Ascites
 Polycystic ovary syndrome (high androgen levels)

29
Q

Potassium-sparing diuretics: aldosterone antagonists adverse effects

A

 Gynecomastia in male patients
 Menstrual irregularities in female patients
 Hyperkalemia
 Mental confusion

30
Q

Potassium-sparing diuretics: Sodium channel blockers

A
  • the Na/K counterstransport blocked
     Not very efficacious
     Used in combination with other diuretics for potassium sparing effects
     Prevent the loss of potassium that occurs with thiazide and loop diuretics
31
Q

Potassium-sparing diuretics: Sodium channel blockers adverse effects

A

 Increased uric acid
 Renal stones
 K+ retention

32
Q

Carbonic Anhydrase inhibitors

A

 Much less efficacious than thiazide or loop diuretics
 Often used for other pharmacologic actions
 Inhibits carbonic anhydrase of proximal tubule

33
Q

Carbonic Anhydrase inhibitors therapeutic uses

A

 Glaucoma
 Correction of metabolic alkalosis
 Mountain sickness

34
Q

Osmotic diuretics - Mannitol (osmitrol)

A

 Alcohol and a sugar (similar to xylitol or sorbitol)
 Not absorbed orally
 IV

35
Q

Osmotic diuretics - Mannitol (osmitrol) mechanism of action

A

 Elevates blood plasma osmolality
 Enhanced flow of water from tissues into the plasma
 Elevates tubular filtrate osmolality
 Filtered, but not reabsorbed
 Facilitates water excretion
 Reduces water reabsorption
 Inhibits reabsorption of sodium, chloride, and other solutes

36
Q

Osmotic diuretics therapeutic uses

A
 Reduce intracranial pressure
 Acute renal failure
         Shock
         Drug toxicity
         Trauma
         Maintaining urine flow preserves long term kidney function!